# First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

> **NCT06554795** · PHASE1,PHASE2 · RECRUITING · sponsor: **DualityBio Inc.** · enrollment: 360 (estimated)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **DRUG:** DB-1419

## Key facts

- **NCT ID:** NCT06554795
- **Lead sponsor:** DualityBio Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-03
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06554795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06554795, "First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06554795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*